Stock OTLK OUTLOOK THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Comparison Chart Outlook Therapeutics, Inc.

Equities

OTLK

US69012T3059

Real-time Estimate Cboe BZX
Other stock markets
 10:05:56 05/06/2024 pm IST 		5-day change 1st Jan Change
7.375 USD +2.57% Intraday chart for Outlook Therapeutics, Inc. +3.93% -5.96%
28/05 Outlook Therapeutics Granted EU Marketing Authorization for Lytenava to Treat Wet AMD MT
28/05 Outlook Therapeutics, Inc. Receives European Commission Marketing Authorization for LYTENAVA? (bvacizumab grapa) for the Treatment of Wet AMD CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
OUTLOOK THERAPEUTICS, INC.
Other Biotechnology & Medical Research
+3.06%+3.93%-5.96%-78.83%-82.27% 168M
Bearish
Neutral
Bearish

Technical Rankings Surperformance

  1. Stock Market
  2. Equities
  3. OTLK Stock
  4. Charts Outlook Therapeutics, Inc.
  5. Comparison Chart